In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a ...

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...

It’s been one week since Wanda Lee-Ballou received University of Virginia (UVA) Health’s first dose of Ocravus Zunovo – the ...

What used to take hours, we can now do in less than 30 minutes”: FDA OKs new treatment for people suffering from multiple ...

A recent study showed that both cognitive behavioral therapy (CBT) and the mild stimulant modafinil (Provigil) reduced MS ...

Researchers have found that combining tolerogenic dendritic cells with Dimethyl Fumarate improves treatment efficacy for ...

It is hoped the discovery by Edinburgh University can be adapted to treat humans after being tested on mice. A woman with ...

The University of Virginia’s (UVA) health system has become one of the first in the country to administer a groundbreaking ...

Multiple sclerosis is a complex and challenging condition to manage, but a wide range of therapies offers hope for patients.

The National MS Society has awarded $4.6 million in funding for five research projects aiming to help restore lost function ...

Sanofi stopped a Phase 2 study of oditrasertib in relapsing and progressive MS after it failed to lower blood NfL levels ...